K-pop

Son Seung-yeon Releases "Today's Me," a Healing Song She Co-Composed

Combining a lyrical band sound with delicate vocals

KIM HYUNSIK
2026-10-23 11:55:14
[Edaily Starin Reporter KIM HYUNSIK ] Singer Son Seung-yeon will release her new song “Today’s Me” at 6 p.m. on the 23rd via various online music platforms.
Son Seung-yeon
“Who I Am Today” Cover Art
“Who I Am Today” is a warm, soothing song that explores the moment when, amid the monotony of daily life, one suddenly pauses to reflect on where they are headed. The lyrics capture the emotions felt while comparing the adult self one dreamed of as a child with who they are now, along with a resolution to move toward a better tomorrow.
Son Seung-yeon’s delicate vocals are layered over a lyrical and gentle band sound. Moving away from her previous style, which emphasized her signature explosive vocal power, Son Seung-yeon has placed greater emphasis on lyricism and comfort. She also participated in the composition process, showcasing her talents as a singer-songwriter.
Son Seung-yeon, a former winner of Mnet’s “Voice Korea,” is active across both the music and musical theater industries. This year, she appeared in the musical “Hell’s Kitchen” and on MBC’s “The Top Contenders.” She went on to win the grand prize on “The Top Contenders,” a show billed as the ultimate audition competition.

Economy

Corporation

IT·Science

Economy

Shifting from Short-Term to Medium- and Long-Term... Appeal of Commercial Paper as a Funding Source Plummets

Fluctuations in credit spreads serve as an indicator of investor sentiment and capital flows in the corporate bond market. “Credit Signal” provides an intuitive analysis of the market’s overall trends…
2026-10-23 17:57:04

Corporation

Jeong Yong-jin Starts by Replacing E-MART Co., Ltd.’s CEO… Appoints Entire Executive Team in Their 40s

Shinsegae Co.,Ltd Chairman Chung Yong-jin is returning to the forefront of management at E-MART Co., Ltd.(139480). Unlike in 2013, when he stepped down as a registered director and entrusted the busin…
2026-10-23 14:55:06

IT·Science

HANALL BIOPHARMA CO.,LTD’s ‘Batoclimab’ Receives First New Drug Approval in China Nine Years After Technology Export

“Batoclimab,” a treatment for autoimmune diseases developed by HANALL BIOPHARMA CO.,LTD(009420), has received new drug approval in China. This comes approximately nine years after the company licensed…
2026-10-23 21:05:02